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Expression of N-cadherin an adhesion molecule of the cadherin family, in tumor
cells is associated with their increased invasive potential. Many studies suggested the
role of N-linked oligosaccharides as important factors that contribute to metastasis by
influencing tumor cell invasion and adhesion. N-cadherin is a heavily glycosylated
protein. We have analysed the carbohydrate profile of this protein synthesized in hu-
man melanoma cell lines: WM35 from the primary tumor site and WM239, WM9, and
A375 from different metastatic sites. N-cadherin was immunoprecipitated with
anti-human N-cadherin polyclonal antibodies. Characterisation of its carbohydrate
moieties was carried out by SDS/PAGE electrophoresis and blotting, followed by im-
munochemical identification of the N-cadherin polypeptides and analysis of their
glycans using highly specific digoxigenin or biotin labelled lectins. The positive reac-
tion of N-cadherin from the WM35 cell line with Galanthus nivalis agglutinin (GNA),
Datura stramonium agglutinin (DSA) and Sambucus nigra agglutinin (SNA) indicated
the presence of high-mannose type glycans and biantennary complex type oligosac-
charides with 2–6 linked sialic acid. N-cadherin from WM239, WM9, and A375 cell
lines gave a positive reaction with Phaseolus vulgaris leukoagglutinin (L-PHA) and lo-
tus Tetragonolobus purpureas agglutinin (LTA). This indicated the presence of tri- or
tetra-antennary complex type glycans with -fucose. In addition, N-cadherin from
WM9 (lymphomodus metastatic site) and A375 (solid tumor metastatic site) contained
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complex type chains with 2–3 sialic acid (positive reaction with Maackia amurensis
agglutinin — MAA).
The results demonstrated that N-glycans of N-cadherin are altered in metastatic mel-
anomas in a way characteristic for invasive tumor cells.
The pattern of expression of cell adhesion
molecules and their properties play a pivotal
role in controlling the primary processes of
cell division, migration, differentiation and
death.
Cadherins are transmembrane glyco-
proteins, which provide strong intercellular
adhesion in Ca2+ dependent manner. Classic
cadherins are composed of a large extra-
cellular domain, which mediates homophilic
type cell adhesion, a transmembrane domain,
and a highly conserved cytoplasmic domain,
which interacts with actin cytoskeleton. Many
different cadherins are known, the predomi-
nant ones being E-cadherin (cell-CAM 120/80,
Arc-1, uvomorulin), N-cadherins (A-CAM,
N-cal-CAM), and P-cadherin (placental
cadherin). Cadherins play a major role in epi-
thelial cell–cell adhesion; moreover, their role
in cell differentiation, transformation, and in-
vasion has been also documented (Freemont
& Hoyland, 1996; Menger & Vollmar, 1996;
Alpin et al., 1999; Hazan et al., 2000). Normal
cultured human melanocytes express both
E-cadherin and P-cadherin, but it is
E-cadherin that is primarily responsible for
adhesion of melanocytes to keratinocytes
(Tang et al., 1994; Hirohashi, 1998; Hsu et al.,
2000). N-cadherin plays an essential role in
controlling the strength of cell–cell and
cell–matrix interactions. It is expressed by
several human fetal tissues and re-expressed
by the corresponding neoplasm (Hsu et al.,
1996; Sanders et al., 1999).
Changes in cadherin expression in mela-
noma are characterised by a significant loss of
membranous P-cadherin and E-cadherin and
de novo expression of membranous N-cad-
herin (Sanders et al., 1999; Johnson et al.,
1999; Laidler et al., 2000).
Many studies suggested the role of N-linked
oligosaccharides in cancer metastasis by influ-
encing tumor cell adhesion and invasion
(Dall’Olio, 1996; Dennis et al., 1999). In partic-
ular, malignant transformation was associ-
ated with increased size (branching) of
oligosaccharide chains, extensive poly-N-
acetyllactosaminylation and sialylation of
some cell membrane glycoproteins. Human
cancer of breast, colon, bladder, and melano-
mas show increased levels of 1-6GlcNAc
branched N-glycans of tri- and tetra-antennary
type, formed due to the increased activity of
N-acetylglucosaminyltransferase V (Dennis et
al., 1999; Prokopishyn et al., 1999; Datti et al.,
2000). The appearance of N-linked glycans
with 1-6GlcNAc branches in rodent tumor
models correlates with metastasis and pro-
gression of tumor (Datti et al., 2000). More-
over, sialoglycans on the surface of human co-
lon cancer cell have been implicated in cellu-
lar adhesion and metastasis. The common
structural motif among adhesion molecules in
colon cells is the terminal NeuAc2,3Gal-R
glycosidic linkage.
Recent analysis of N-glycosylation profile of
proteins from various melanoma cells indi-
cated N-cadherins as one of the proteins un-
dergoing changes in oligosaccharide composi-
tion in different cancer melanoma cell lines
(Lityñska et al., 2001).
This a novel finding that carbohydrates of
N-cadherin precipitated from the cell line
from primary melanoma site differ from those
of N-cadherin precipitated from cell lines de-
rived from metastatic sites in different or-
gans.
MATERIALS AND METHODS
Materials. All standard chemicals of analyt-
ical grade were purchased from Sigma.
Cell lines.Melanoma cell lines were obtained
from the Department of Cancer Immunology,
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University School of Medical Sciences at
Great-Poland Cancer Centre (Poznañ, Poland).
The WM35 line was from the primary radial
growth phase tumor site while WM9 was the
lymph node metastatic line, WM239, the skin
metastatic line (both of them established by
Meenhard Herlyn, The Wistar Institute, Phila-
delphia, U.S.A.), and A375 (ATCC-CRL-1619,
Giard et al., 1973), the solid tumor metastatic
line. The cell lines were cultured in the
RPMI–1640 medium (Sigma) containing 10%
foetal bovine serum (GibcoBRLTM) and antibi-
otics (penicillin 100 U/ml, streptomycin 100
g/ml from Polfa, Tarchomin, Poland). Cells
were incubated at 37C in a humidified atmo-
sphere of 5% CO2 in air.
Homogenisation. Cells were harvested
from culture dishes with a rubber policeman,
washed with phosphate-buffered saline (PBS)
and homogenised on ice by triple sonification,
5 s each (Bandelin Electronic) in 50 mM
Tris/HCl, pH 7.5, containing 1 mM EDTA and
proteinase inhibitor cocktail (Sigma). The ho-
mogenate was left on ice for 1 h with 1% Tri-
ton X-100 and 0.3% protamine sulphate and
centrifuged at 18000  g for 1 h at 4C. Pro-
tein concentration was determined in the
supernatants according to Bradford (1976).
Immunoprecipitation. The cleared cell ho-
mogenate (2.1 mg of total protein) was incu-
bated with 10 g anti-N-cadherin pAb
(Takara) overnight at 4C on an orbital rota-
tor. Afterwards, the sample was mixed with
30 l of homogeneous protein-A agarose sus-
pension (Boehringer Mannheim) and agitated
for 3 h at 4C on a orbital rotator. Immuno-
precipitates were washed: twice with 50 mM
Tris/HCl buffer, pH 7.5, containing 150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, and proteinase inhibitor cock-
tail; twice with 50 mM Tris/HCl buffer, pH
7.5, containing 500 mM NaCl, 0.1% Nonidet
P-40, 0.05% sodium deoxycholate and finally
twice with 50 mM Tris/HCl buffer, pH 7.5,
supplemented with 0.1% Nonidet P-40 and
0.05% sodium deoxycholate. The immuno-
precipitated proteins were eluted by boiling
the immunoprecipitates for 5 min in
SDS/PAGE sample buffer (125 mM Tris/HCl,
pH 6.8, 2% SDS, 2% mercaptoethanol and 10%
glycerol) and separated by SDS/PAGE.
Gel electrophoresis. The gel (85 70 1.5
mm) was prepared in the presence of SDS us-
ing a discontinuous buffer system according
to Laemmli (1970). Immunoprecipitates
(300 g of total protein per lane) of human
melanoma cell lines (WM35, WM239, WM9,
A375) were separated using 4.5% stacking and
8% separation gel in 4 h run.
Western blotting. Proteins were trans-
ferred onto PVDF membrane overnight using
a Trans-Blot Electrophoretic Transfer Cell
(Bio-Rad) at 150 mA in 25 mM Tris, 192 mM
glycine, 20% methanol at pH 8.4.
Immunodetection of N-cadherin. The
PVDF membrane was blocked for 3 h at room
temperature in TBS/Tween (50 mM Tris, 150
mM NaCl, 0.1% Tween 20, pH 7.5) containing
2% BSA (bovine serum albumin). The blot was
incubated for 1 h with rabbit anti-human
N-cadherin (Takara) diluted 1:1000 in 2%
BSA/TBS/Tween. Afterwards, it was washed
three times for 15 min each with TBS/Tween,
and incubated for 1 h with goat anti-rabbit
IgG-AP conjugate (Sigma at 1:4000 dilution in
1% BSA/TBS/Tween). Subsequently, the blot
was washed three times with TBS/Tween, fol-
lowed by a triple wash with TBS for 5 min
each. N-cadherin was detected using NBT/X
phosphate solution (NBT, 4-nitro blue tetra-
zolium chloride, X-phosphate, 5-bromo-4-
chloro-3-indolyl phosphate, Boehringer Man-
nheim) in 100 mM Tris/HCl with 50 mM
MgCl2, 100 mM NaCl, pH 9.5.
Lectin analysis. The PVDF membrane was
incubated overnight in blocking reagents
(Boehringer Mannheim) at 4C. The blot was
washed twice with TBS and once with lectin
buffer 1 (TBS, 1 mM MgCl2, 1 mM MnCl2,
1 mM CaCl2, pH 7.5). Subsequently, the blot
was incubated for 1 h with digoxigenin la-
belled lectins, GNA, SNA, DSA (1 g/ml dilu-
tion in buffer 1) and MAA (5 g/ml dilution in
buffer 1), or biotin labelled lectin L-PHA, LTA
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(5 g/ml dilution in buffer 1). The membrane
was washed three times with TBS and incu-
bated with anti-digoxigenin–AP conjugate di-
luted 1:1000 in TBS or Extr Avidin-AP conju-
gate (Sigma) diluted 1:1000 in TBS. The
lectins were detected using NBT/X phosphate
in 0.1 M Tris/HCl, 0.05 M MgCl2, 0.1 M NaCl,
at pH 9.5.
RESULTS
N-cadherin was immunoprecipitated from
four melanoma cell lines: WM35 (from the pri-
mary tumor radial phase), WM239, WM9,
and A375 (from metastatic sites).
N-cadherin immunoprecipitated from vari-
ous melanoma cell lines was identified with
rabbit anti human N-cadherin antibody as a
133 kDa polypeptide (Fig. 1), which corre-
sponded well to the values reported for this
cell adhesion molecule in various human cells
(Dufour et al., 1999; Hazan et al., 2000;
Laidler et al., 2000).
Glycan chain analysis performed with the
use of digoxigenin labelled lectins, GNA, SNA,
MAA and DSA and biotin labelled lectins,
L-PHA and LTA, allowed for characterisation
of the oligosaccharide component of this cell
adhesion molecule. The carbohydrate moi-
eties of N-cadherin from all studied human
melanoma cell lines are presented in Table 1.
The positive response of N-cadherin from
the primary tumor, the WM35 cell line, with
GNA, DSA, and SNA indicated the presence
of high-mannose type glycan and complex
biantennary type ones with 2–6 linked sialic
acid (Fig. 2A, B, C). Additionally, N-cadherin
from WM239, WM9, and A375 cell lines that
underwent metastasis gave a positive re-
sponse with L-PHA and LTA (Fig. 2E, F). The
positive reaction with L-PHA suggested the
presence of 1,6 GlcNAc branched tri- or
tetra-antennary complex type glycan (Fig.
2E). The presence of -fucose was demon-
strated by a positive reaction with LTA lectin
(Fig. 2F). N-cadherin from WM9 (lym-
phomodus metastatic site) and A375 (solid tu-
mor metastatic site) contained also complex
type chains with 2,3-linked sialic acid that
was shown to result in their positive reaction
with MAA (Fig. 2D).
DISCUSSION
We have recently reported that the expres-
sion of N-cadherin in various melanoma cell
lines was associated with the absence of
E-cadherin, commonly viewed as a tumor sup-
pressor cell adhesion molecule (Laidler et al.,
2000). Parallel studies have been carried out
on the profile of N-glycosylation of proteins
from the same melanoma cell lines. The re-
sults suggested that N-cadherin might belong
to the proteins undergoing changes in
glycosylation due to metastasis (Lityñska et
al., 2001).
In normal epidermis, E-cadherin serves as
an intercellular glue between melanocytes
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Figure 1. Western blot analysis of immuno-
precipitates of N-cadherin from human melanoma
cell lines.
The cell extracts (300 g of total protein) of the lines:
A375 (lane 1), WM9 (lane 2), WM35 (lane 3), and
WM239 (lane 4) were immunoprecipitated with anti
N-cadherin pAb as described in Materials and Methods.
After precipitation, the samples were analysed by
SDS/PAGE using 8% gel, transferred onto a PVDF
membrane and immunodetected with anti-N-cadherin
pAb. HMW, high molecular mass standards stained
with Amino-black.
and keratinocytes, enabling gap junctional
communication. During melanoma develop-
ment and progression, loss of E-cadherin and
upregulation of N-cadherin expression results
in a switch of communication partners to
N-cadherin expressing melanoma cells and ad-
jacent dermal fibroblasts (Hsu et al., 1996;
2000). A promoter role for N-cadherin in inva-
sion of various human cancers, including
breast (Hazan et al., 2000), prostate
(Bussemakers et al., 2000), stomach, and mel-
anoma (Sanders et al., 1999; Herlyn et al.,
2000) has been implicated. A cell line with a
low invasion rate was converted to a highly in-
vasive one by transfection and expression of
N-cadherin (Nieman et al., 1999).
While there seems to be no doubt with re-
spect to the crucial role of N-cadherin expres-
sion in melanoma progression, little is know
about its carbohydrate moiety. Studies from
many laboratories demonstrated the impor-
tance of oligosaccharide component of
glycoproteins in stabilisation of protein con-
formation, as well as in modulation of their
physicochemical properties and biological
function (Dall’Olio, 1996; Laidler & Lityñska,
1997; Dennis, 1999a). Altered glycosylation of
glycoproteins is one of the many molecular
changes that accompany tumorogenesis and
malignant transformation. Generally, the
most frequently observed cancer related
changes in the pattern of glycosylation in-
clude the synthesis of highly branched,
N-acetyllactosaminylated and heavily sialyl-
ated N-linked glycans (Pierce et al., 1997;
Dimitroff et al., 1999; Dall’Olio et al., 2000,
Petretti et al., 2000).
The results reported here on lectin analysis
of immunoprecipitated N-cadherin clearly
pointed out the differences in glycosylation
pattern between the N-cadherin from primary
tumor (WM35) and N-cadherin from meta-
stases (WM239, WM9, and A375). Tri- or
tetra-antennary complex type sialylated and
fucosylated glycans are specifically present in
N-cadherin from all metastases, while absent
in this protein from primary radial phase
(WM35).
At present there is no evidence that the ob-
served changes in N-glycosylation of
N-cadherin in melanoma cell lines are directly
related to melanoma progression and increas-
ing invasiveness. However, the fact that
N-cadherin, expressed in primary radial phase
melanoma cells (WM35), bears no highly
branched and less 2,3-sialylated and fuco-
sylated glycans when compared to all meta-
static melanomas (WM9, WM 239, A375) sug-
gests a possible association of the oligo-
saccharide component with cancer progres-
sion. Perhaps one of the critical steps in cre-
ation of invasive phenotype is the increased
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Table 1. Carbohydrate components of N-cadherin from melanoma cell lines
Lectin Specificity
Cell line
WM35 WM239 WM9 A375
GNA
2Man
Man1-(3)Man
6Man
+ + + +
DSA Gal1-4GlcNAc + + + +
SNA NeuAc2–6Gal + + + +
MAA NeuAc2–3Gal – – + +
L-PHA
1-6GlcNAc
branching
– + + +
LTA -Fuc – + + +
expression of respective glycosyltransferases:
2,3- and 2,6-sialyltransferases, fucosyl-
transferase, and GlcNAc-TV accompanying
enhanced expression of N-cadherin.
The only observed difference in glycans of
N-cadherin between metastatic melanoma
lines was the lack of 2,3-sialylation metastatic
melanocytes from skin. However, generally it
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Figure 2. Analysis of N-glycans of N-cadherin from human melanoma cell lines with lectins: A, GNA; B,
DSA; C, SNA; D, MAA; E, L-PHA; F, LTA.
The cell extracts (300 g of total protein) of the lines: A375 (lane 1), WM9 (lane 2), WM35 (lane 3), and WM239
(lane 4) were immunoprecipitated with anti N-cadherin pAb as described in Materials and Methods. After precipita-
tion the samples were analysed by SDS/PAGE using 8% acrylamide gel, transfered onto a PVDF membrane and
immunodetected with anti-N-cadherin pAb (lane 1) or stained with labelled and immunoanalysed lectins (lanes
2–5): 2, A375 cell line; 3, WM9 cell line; 4, WM35 cell line; 5, WM239 cell line; HMW, high molecular mass stan-
dards stained with Amino-black.
appears that 2,3-sialylation is important in
determination of metastasis. About 90% of co-
lon cancers of I and II grade show an increased
activity of2,6-sialyltransferase and give a pos-
itive response with SNA lectin, specific for
2,6-linked sialic acid (Dall’Olio et al., 2000).
Loss of 2,6-sialylation in mutant of B16 mela-
noma is associated with a loss of metastatic po-
tential (Dennis et al., 1999). While there is no
question on the role of 2,6-sialylation and in-
creased expression of respective sialyltrans-
ferase accompanying cancer progression
(Dall’Olio et al., 2000), few reports indicate a
specific role of 2,3-sialylation (Pousset et al.,
1997). According to Dimitroff et al. (1999) in
colon cancer cells the 2,3-linked sialic acid
bearing proteins are essential in mediating
intercellular adhesion. In the melanoma cell
lines, except for that derived from skin, investi-
gated in the present and previous reports
(Dimitroff et al., 1999), 2,3-sialylation is
found to be an important factor in determining
the course of metastasis.
The presented results characterised the
oligosaccharide component of N-cadherin
from melanoma cell lines from different or-
gans and demonstrated that N-glycans of
N-cadherin are altered in metastatic mela-
noma cell lines in a way typical for invasive tu-
mor cell N-glycans.
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